Literature DB >> 24057572

In vitro kinetics of nerve agent degradation by fresh frozen plasma (FFP).

Timo Wille1, Horst Thiermann, Franz Worek.   

Abstract

Great efforts have been undertaken in the last decades to develop new oximes to reactivate acetylcholinesterase inhibited by organophosphorus compounds (OP). So far, a broad-spectrum oxime effective against structurally diverse OP is still missing, and alternative approaches, e.g. stoichiometric and catalytic scavengers, are under investigation. Fresh frozen plasma (FFP) has been used in human OP pesticide poisoning which prompted us to investigate the in vitro kinetics of OP nerve agent degradation by FFP. Degradation was rapid and calcium-dependent with the G-type nerve agents tabun, sarin, soman and cyclosarin with half-lives from 5 to 28 min. Substantially longer and calcium-independent degradation half-lives of 23-33 h were determined with the V-type nerve agents CVX, VR and VX. However, at all the tested conditions, the degradation of V-type nerve agents was several-fold faster than spontaneous hydrolysis. Albumin did not accelerate the degradation of nerve agents. In conclusion, the fast degradation of G-type nerve agents by FFP might be a promising tool, but would require transfusion shortly after poisoning. FFP does not seem to be suitable for detoxifying relevant agent concentrations in case of human poisoning by V-type nerve agents.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24057572     DOI: 10.1007/s00204-013-1130-5

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  4 in total

1.  Catalytic Soman Scavenging by the Y337A/F338A Acetylcholinesterase Mutant Assisted with Novel Site-Directed Aldoximes.

Authors:  Zrinka Kovarik; Nikolina Maček Hrvat; Maja Katalinić; Rakesh K Sit; Alexander Paradyse; Suzana Žunec; Kamil Musilek; Valery V Fokin; Palmer Taylor; Zoran Radić
Journal:  Chem Res Toxicol       Date:  2015-04-16       Impact factor: 3.739

2.  A case report of cholinesterase inhibitor poisoning: cholinesterase activities and analytical methods for diagnosis and clinical decision making.

Authors:  N Amend; J Langgartner; M Siegert; T Kranawetvogl; M Koller; H John; C Pflügler; C Mögele-Schmid; F Worek; H Thiermann; T Wille
Journal:  Arch Toxicol       Date:  2020-04-17       Impact factor: 5.153

3.  In Vitro Interaction of Organophosphono- and Organophosphorothioates with Human Acetylcholinesterase.

Authors:  Franz Worek; Horst Thiermann; Marianne Koller; Timo Wille
Journal:  Molecules       Date:  2020-07-02       Impact factor: 4.411

4.  Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers.

Authors:  S S Terekhov; I V Smirnov; O G Shamborant; T V Bobik; D G Ilyushin; A N Murashev; I A Dyachenko; V A Palikov; V D Knorre; A A Belogurov; N A Ponomarenko; E S Kuzina; D D Genkin; P Masson; A G Gabibov
Journal:  Acta Naturae       Date:  2015 Oct-Dec       Impact factor: 1.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.